InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,134.80
(
0.44%
)
Dow Jones
39,357.01
(
0.00%
)
Brent Oil
81.45
(
-0.20%
)
Bitcoin
58,955.63
(
-0.67%
)
Post# of 252864
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 17657
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: jbog post# 114354

Tuesday, 02/08/2011 11:21:14 PM

Tuesday, February 08, 2011 11:21:14 PM

Post# of 252864


While it is somewhat farfetched, I wouldn't put it past Teva if they looked to buy Momenta and fund the whole transaction by selling Momenta's portion of the copaxone franchise to Sandoz.



That would also not fly by the FTC/DoJ very well. You are still putting the only 2 potential Copox products in the same hands.

EDIT: Miss-read your post, I agree that would work but why would TEVA care to do so?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up